投资公司刺激并削减ResMed的股权,而ResMed报告其收入丰厚,超过2.43 EPS。 Investment firms boost and cut stakes in ResMed, which reported strong earnings, exceeding $2.43 EPS.

内华达州的超级和投资顾问公司购买了医疗设备供应商ResMed公司的股份,而Covestor有限公司则减少了股份。 Aware Super and Investment Counsel Co. of Nevada purchased shares of ResMed Inc., a medical equipment provider, while Covestor Ltd. reduced its holdings. ResMed报告该季度的EPS为2.43美元,超过了估计数。 ResMed reported $2.43 EPS for the quarter, exceeding estimates. 股价是249.73美元的目标价。 The stock has a "Moderate Buy" rating with a target price of $249.73. ResMed在睡眠和呼吸护理和软件服务中运作,为呼吸系统紊乱提供设备。 ResMed operates in Sleep and Respiratory Care and Software as a Service, providing equipment for respiratory disorders.